Please rate the overall quality of the conference.
Please rate the overall quality of the session.
How did you hear about the conference? (Mark all that apply)
Please rate the overall teaching methods used by the presenter of this session.
Please rate the overall teaching methods used by the presenters of this session.
I based my decision to come on the following reason (please rank in order, with 1 being the most important):
Speakers
Please rate the extent to which the following statements are true:
The material will enhance my practice.
The material presented will enhance my practice.
Please rate teh extent to which the following statements are true:
Workshop selections
The session was well organized.
CNE contact hours
Please rate the presenter Joseph Bikowski.
Please rate the presenters as a group: Lakshi Aldredge and Liz Horn.
Please rate the presenters as a group: Maryellen Maguire-Eisen, Marianne O'Donoghue, Darrel Rigel, Krista Rubin and Marianne Tawa.
Please rate the presenters as a group: Lucinda Whitney, Jeffrey Hsu, Diane Hanna, Ashish Bhatia, Patty Owens, Penny Smalley.
Please rate the presenters as a group: Marianne Tawa, Diya Mutasim, Noreen Heer Nicol, Lisa Webber, Karrie Fairbother and Susan Tofte.
Please rate the presenters as a group: Barbara Brown, Patricia McClelland, and Jo Ellen Nicholson
Please rate the presenters as a group: Hilary Baldwin, Liz Horn and Carlos Nousari.
Location/time of year
Affordability
Please rate the extent to which you are now able to:
Describe 2 factors that contribute to the burden of psoriatic disease.
Discuss the epidemilogy and types of skin cancer, identify diagnositc clues and clinical presentation, and discuss principles of management.
Define the basic structure and function of the skin.
Identify three skin disorders that would be appropriate for phototherapy and their outcomes.
Correlate the clinical, histological, immunofluorescnece, and serological findings in vasculitis and connective tissue diseases.
Discuss benefits, risks and appropriate use of high-potency topical corticosteroids.
Networking
Describe 3 co-morbidities associated with psoriatic disease.
Discuss the epidemilogy of dysplastic nevi and malignant melanoma skin cancer, identify diagnositc resources for early diagnosis and principles of management.
Describe proper patient assessment prior to selecting a vein procedure such as sclerotherapy.
Differentiate primary and secondary lesions and discuss their location, arrangement and distribution.
Describe the differences between UVA and UVB light.
Identify ways to diagnose vasculitis & connective tissue diseases.
Identify cutaneous side effects that occur as a result of inappropriate or chronic over-use of topical corticosteroids.
Describe 3 patient teaching points that will assist in identifying co-morbid conditions in psoriatic patients.
Describe the key physical examination features associated with patch, plaque, tumor and erthrodermic stage disease; list at least 3 diagnostic tests; and outline the aims of intervention for both early and later stage CTCL.
Discuss the clinical features, differential diagnoses, diagnostic techniques, and pertinent interventions for commonly encountered skin disorders.
Identify the three types of lamps used in phototherapy and describe the difference between internal and external metered equipment.
Name at least 2 research types.
Please rate the value of the syllabus/hand-out materials.
Discuss ways to promote safe use of long-term topical corticosteroids and alternative and combination therapies to use adjunctively.
List the differences between UVB and PUVA protocols.
Describe the limitations to research results.
Discuss the types and protective quality of common sunscreens, Identify important patient education instructions, and explore new FDA monograph and its impact on sunscreen selection and use.
Would you say your personal objectives were met?
Please rate the extent to which you agree with the following statements:
The syllabus/hand out materials were valuable.
Recognize the benefits of moisturizers and emollient products containing alpha-hydroxy acid (AHA) for barrier therapy and for maintenance of overall skin health.
Develop education strategies specific for the patient, the family, the public and professional colleagues.
Describe the grades and management of erythema and itch for patients receiving phototherapy.
Discuss the evaluation of clinical research.
Identify characteristics of indoor tanners; discuss associated acute and long-term risks; and define patient education messages that combat indoor tanning behaviors.
The teaching methods were appropriate.
Describe 3 messages that should be discussed when teaching photo protection.
Describe ways to shield and identify appropriate shielding material.
Describe at least one mechanism for the development of bacterial resistance.
The educational content was scientifically sound.
Discuss the advanced techniques in mid to lower face rejuvenation and selection of correct laser settings as well as adjunctive cosmetic procedures.
Identify what makes a successful phototherapy unit and describe some documentation pitfalls.
Describe at least one strategy for preventing bacterial resistance.
The program gave a balanced view of therapeutic options, including use of generic names.
Discuss selection process for adjunctive cosmetics lines, how to maximize margins and minimize overhead.
There was an opportunity to network with colleagues.
Was this session was free from commercial bias?
Discuss wide variety of topics and issues of concern to professionals working in cosmetic dermatology and describe what makes a successful cosmetic dermatology practice.
The registration procedures were organized and efficient.
If commercial bias was noted, please describe the circumstance.
The physical facilities were appropriate.
Please rate the extent to which you agree that the content and objectives of this activity were relevant to the following goals:
Generate a plan for utilizing knowledge gained about dermatology diseases and disorders that will increase the quality of care patients receive.
Examine the challenges, and the professional and practice issues that impact the quality of care for dermatology patients.
Network with colleagues and professional contacts in promoting dermatology care as an integral part of the health system.
Did you learn anything that you intend to integrate into your practice?
